TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Kennedy, Hutchison Introduce Long-Awaited Bill To Reauthorize The National Cancer Program April 3, 2009